Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children
- 15 August 1985
- Vol. 56 (4) , 738-741
- https://doi.org/10.1002/1097-0142(19850815)56:4<738::aid-cncr2820560406>3.0.co;2-o
Abstract
Fourteen children with mediastinal lymphoblastic lymphoma (MLL) were treated with the six-drug APO protocol. This regimen includes aggressive intermittent chemotherapy and prophylactic central nervous system therapy. Mediastinal irradiation was given only for emergency relief of mediastinal compression (two children) or for incomplete resolution of mediastinal widening with chemotherapy (one child). All 14 patients achieved complete remission; only 1 has relapsed. Toxicities were not severe. APO is effective therapy for children with MLL. APO should receive further trials in children and adults with T-cell lymphoblastic lymphomas.This publication has 24 references indexed in Scilit:
- Pediatric oncology group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)Cancer, 1985
- Childhood Non-Hodgkin's LymphomaNew England Journal of Medicine, 1983
- Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumorBlood, 1982
- Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapseLeukemia Research, 1982
- Lymphoblastic lymphoma: A clinicopathologic study of 95 patientsCancer, 1981
- Non-Hodgkin's lymphoma in children.A progress report on the original patients treated with the LSA2-L2 protocolCancer, 1979
- Improved prognosis for patients with mediastinal lymphoblastic lymphomaBlood, 1979
- Malignant lymphoma, lymphoblasticCancer, 1976
- Undifferentiated Lymphoma, Non-Burkitt's TypeAmerican Journal of Diseases of Children, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958